Avenue Therapeutics Inc (ATXI)
2.01
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
2.01
0.00 (0.00%)
After-Hours: 20:00
Avenue Therapeutics Enterprise Value: 0.2873M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 0.2873M |
| November 21, 2024 | 0.2873M |
| November 20, 2024 | 0.2873M |
| November 19, 2024 | 0.2109M |
| November 18, 2024 | 0.077M |
| November 15, 2024 | 0.1344M |
| November 14, 2024 | 0.0388M |
| November 13, 2024 | 0.1726M |
| November 12, 2024 | 0.3352M |
| November 11, 2024 | 0.2682M |
| November 08, 2024 | -0.0418M |
| November 07, 2024 | 0.1186M |
| November 06, 2024 | 0.0384M |
| November 05, 2024 | 0.0063M |
| November 04, 2024 | -0.0258M |
| November 01, 2024 | 0.0384M |
| October 31, 2024 | 0.2951M |
| October 30, 2024 | 0.2951M |
| October 29, 2024 | 0.3753M |
| October 28, 2024 | 0.4876M |
| October 25, 2024 | -0.0258M |
| October 24, 2024 | -0.3145M |
| October 23, 2024 | -0.1862M |
| October 22, 2024 | -0.1701M |
| October 21, 2024 | -0.3466M |
| Date | Value |
|---|---|
| October 18, 2024 | -0.1701M |
| October 17, 2024 | -0.3626M |
| October 16, 2024 | -0.1541M |
| October 15, 2024 | -0.2022M |
| October 14, 2024 | -0.3065M |
| October 11, 2024 | -0.2503M |
| October 10, 2024 | -0.3145M |
| October 09, 2024 | -0.3787M |
| October 08, 2024 | -0.3947M |
| October 07, 2024 | -0.3787M |
| October 04, 2024 | -0.2263M |
| October 03, 2024 | 0.1667M |
| October 02, 2024 | 0.3272M |
| October 01, 2024 | 0.2951M |
| September 30, 2024 | 0.4395M |
| September 27, 2024 | -2.263M |
| September 26, 2024 | -2.499M |
| September 25, 2024 | -2.650M |
| September 24, 2024 | -2.635M |
| September 23, 2024 | -2.435M |
| September 20, 2024 | -2.335M |
| September 19, 2024 | -2.12M |
| September 18, 2024 | -1.991M |
| September 17, 2024 | -1.905M |
| September 16, 2024 | -1.862M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.882M
Minimum
Aug 06 2024
195.54M
Maximum
Sep 14 2020
42.58M
Average
7.731M
Median
Enterprise Value Benchmarks
| Fortress Biotech Inc | 5.421M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.076M |
| Total Expenses (Quarterly) | 3.156M |
| EPS Diluted (Quarterly) | -1.92 |
| Earnings Yield | -1.09K% |